Sign In
Buy HSTM
HealthStream Earnings Calls
| Release date | May 04, 2026 |
| EPS estimate | $0.160 |
| EPS actual | $0.200 |
| EPS Surprise | 25.00% |
| Revenue estimate | 79.68M |
| Revenue actual | 81.203M |
| Revenue Surprise | 1.91% |
| Release date | Feb 23, 2026 |
| EPS estimate | $0.160 |
| EPS actual | $0.180 |
| EPS Surprise | 12.50% |
| Revenue estimate | 76.204M |
| Revenue actual | 79.708M |
| Revenue Surprise | 4.60% |
| Release date | Nov 03, 2025 |
| EPS estimate | $0.170 |
| EPS actual | $0.200 |
| EPS Surprise | 17.65% |
| Revenue estimate | 76.207M |
| Revenue actual | 76.474M |
| Revenue Surprise | 0.351% |
| Release date | Aug 04, 2025 |
| EPS estimate | $0.160 |
| EPS actual | $0.180 |
| EPS Surprise | 12.50% |
| Revenue estimate | 75.731M |
| Revenue actual | 74.396M |
| Revenue Surprise | -1.76% |
Last 4 Quarters for HealthStream
Below you can see how HSTM performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 04, 2025 |
| Price on release | $26.05 |
| EPS estimate | $0.160 |
| EPS actual | $0.180 |
| EPS surprise | 12.50% |
| Date | Price |
|---|---|
| Jul 29, 2025 | $26.53 |
| Jul 30, 2025 | $26.32 |
| Jul 31, 2025 | $26.16 |
| Aug 01, 2025 | $25.65 |
| Aug 04, 2025 | $26.05 |
| Aug 05, 2025 | $25.74 |
| Aug 06, 2025 | $26.09 |
| Aug 07, 2025 | $25.94 |
| Aug 08, 2025 | $25.98 |
| 4 days before | -1.81% |
| 4 days after | -0.269% |
| On release day | -1.19% |
| Change in period | -2.07% |
| Release date | Nov 03, 2025 |
| Price on release | $25.32 |
| EPS estimate | $0.170 |
| EPS actual | $0.200 |
| EPS surprise | 17.65% |
| Date | Price |
|---|---|
| Oct 28, 2025 | $25.83 |
| Oct 29, 2025 | $24.60 |
| Oct 30, 2025 | $24.55 |
| Oct 31, 2025 | $24.60 |
| Nov 03, 2025 | $25.32 |
| Nov 04, 2025 | $26.03 |
| Nov 05, 2025 | $25.71 |
| Nov 06, 2025 | $24.77 |
| Nov 07, 2025 | $24.65 |
| 4 days before | -1.97% |
| 4 days after | -2.65% |
| On release day | 2.80% |
| Change in period | -4.57% |
| Release date | Feb 23, 2026 |
| Price on release | $21.24 |
| EPS estimate | $0.160 |
| EPS actual | $0.180 |
| EPS surprise | 12.50% |
| Date | Price |
|---|---|
| Feb 17, 2026 | $20.28 |
| Feb 18, 2026 | $20.00 |
| Feb 19, 2026 | $20.20 |
| Feb 20, 2026 | $20.35 |
| Feb 23, 2026 | $21.24 |
| Feb 24, 2026 | $22.09 |
| Feb 25, 2026 | $21.67 |
| Feb 26, 2026 | $21.33 |
| Feb 27, 2026 | $21.23 |
| 4 days before | 4.73% |
| 4 days after | -0.0471% |
| On release day | 4.00% |
| Change in period | 4.68% |
| Release date | May 04, 2026 |
| Price on release | $21.25 |
| EPS estimate | $0.160 |
| EPS actual | $0.200 |
| EPS surprise | 25.00% |
| Date | Price |
|---|---|
| Apr 28, 2026 | $21.64 |
| Apr 29, 2026 | $21.22 |
| Apr 30, 2026 | $20.76 |
| May 01, 2026 | $20.72 |
| May 04, 2026 | $21.25 |
| May 05, 2026 | $24.36 |
| May 06, 2026 | $23.15 |
| May 07, 2026 | $23.54 |
| May 08, 2026 | $23.96 |
| 4 days before | -1.80% |
| 4 days after | 12.75% |
| On release day | 14.64% |
| Change in period | 10.72% |
HealthStream Earnings Call Transcript Summary of Q1 2026
HealthStream reported a strong Q1 2026 with record revenue of $81.2M (up 10.5% YoY) and record adjusted EBITDA of $20.1M (up 24.1% YoY); operating income rose 71% and net income was $5.9M. Management reaffirmed full-year 2026 guidance: revenue $323M–$330M, net income $20.4M–$22.8M, and adjusted EBITDA $73M–$77M. The quarter combined 5.8% organic growth with 4.7% inorganic growth, with recent acquisitions (Verisys/Versus12 and MissionCare Collective/MyCNAjobs) contributing $3.4M in Q1 and expected to contribute roughly $13M for the year. Key product drivers included strong subscription growth in CredentialStream (+19%), ShiftWizard (+29%), and Competency Suite (+17.3%). Career Networks produced $3.78M this quarter and remain an area of increased investment. Gross margin was 65.8% (slightly above expectations); legacy products contributed ~$7.6M but declined ~16% YoY as migrations continue. Cash and investments totaled $66.5M, no long-term debt, and the company continues active capital allocation: $1M dividend declared, $7.5M of buybacks in Q1 (new $10M repurchase plan authorized), $7.5M CapEx in Q1, and $1.8M in minority ecosystem investments. Management plans to accelerate investments—particularly in AI, Career Networks (sales hires and tech infrastructure), and product development—while maintaining a disciplined capital allocation approach.
